InvestorsHub Logo
Followers 0
Posts 77
Boards Moderated 0
Alias Born 06/02/2017

Re: None

Thursday, 06/15/2017 3:03:28 PM

Thursday, June 15, 2017 3:03:28 PM

Post# of 97078
Investors who want the truth here is another snippet from 2011.

InstaCare Corp. Receives Second Confidential Merger Offer From NASDAQ Traded Company
09 May, 2011, 09:20 ET from InstaCare Corp.


LOS ANGELES, May 9, 2011 /PRNewswire/ -- InstaCare Corp. (OTCQB: ISCR), a leading provider of home and prescription diagnostic products for the chronically ill, including the revolutionary Shasta Genstrip targeted at the $20 billion diabetes care and at-home testing markets, and a leading developer of advanced cell phone centric e-health products and technologies, today acknowledged receipt of a second confidential merger offer from a NASDAQ traded company and has submitted this proposal to its Board of Directors for review.

The Board of Directors of InstaCare Corp. also received and reviewed a prior merger proposal from the same company. This earlier proposal was reviewed by the Board and resulted in rejection, and has subsequently been followed by the InstaCare Board submitting a number of counter proposals.

Robert Jagunich, Chairman of InstaCare Corp. commented, "Although we have received two offers, both at premiums to current market prices, it is the Board's belief that based on our analysis, as verified independently in the Walling reports of January 24 and March 2, InstaCare offers more value to its shareholders by remaining independent. However, the Board is still exploring the current proposal. At this time, even with a proposal in hand, InstaCare continues to explore its options, as well as other shareholder value enhancing opportunities."

Mr. Jagunich continued, "Shareholders do not need to take action at this time. The Board will take action in due course."

For more information about InstaCare Corp., Pharma Tech Solutions, Inc. and/or its revolutionary MD@Hand cell phone centric technologies, please visit the InstaCare web site www.instacare.net or www.pharmatechdirect.com, or call the company at (805) 446-2973.




This 3rd press released merger announcement also got attention and excitement when the stock went from 4 to 8 cents on several million shares. But just like the other 2 announced "nameless" companies, this also did not happen.
TAUG was the more recent one.